Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E

Abstract

These scFv-Fcs antibodies are the first recombinant antibodies neutralizing BoNT/E by targeting its light chain. The human-like nature of the isolated antibodies is predicting a good tolerance for further clinical development.